Zeller T, Hughes M, Tuovinen T, Schillert A, Conrads-Frank A, Ruijter HD, Schnabel RB, Kee F, Salomaa V, Siebert U, Thorand B, Ziegler A, Breek H, Pasterkamp G, Kuulasmaa K, Koenig W, Blankenberg S
The contribution of educational class in improving accuracy of cardiovascular risk prediction across European regions: The MORGAM Project Cohort Component.
Ferrario MM, Veronesi G, Chambless LE, Tunstall-Pedoe H, Kuulasmaa K, Salomaa V, Borglykke A, Hart N, Söderberg S, Cesana G; for the MORGAM Project
Comparison of three troponins as predictors of future cardiovascular events--prospective results from the FINRISK and BiomaCaRE studies.
Neumann JT, Havulinna AS, Zeller T, Appelbaum S, Kunnas T, Nikkari S, Jousilahti P, Blankenberg S, Sydow K, Salomaa V.
The 2nd annual meeting took place in Athens, Greece from Oct 2nd to 5th 2013.
BiomarCaRE researchers Tanja Zeller, Renate Schnabel (both UKE Hamburg) and Arne Schillert (IMBS Lübeck), together with Matthias Heinig (MPIMG Berlin) have been awarded a 3-year, 1.44M Euro grant from the German Federal Ministry of Education and Research (BMBF) under their "Junior e:Med" initiative.
Assessment of microRNAs in patients with unstable angina pectoris.
Zeller T, Keller T, Ojeda F, Reichlin T, Twerenbold R, Tzikas S, Wild PS, Reiter M, Czyz E, Lackner KJ, Munzel T, Mueller C, Blankenberg S.
High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort.
Zeller T, Tunstall-Pedoe H, Saarela O, Ojeda F, Schnabel RB, Tuovinen T, Woodward M, Struthers A, Hughes M, Kee F, Salomaa V, Kuulasmaa K, Blankenberg S; MORGAM Investigators.
The BiomarCaRE and MORGAM partners met at a joint meeting on the island San Servolo, Venice, Italy from Oct 1st to 3rd 2012.